29 reports of this reaction
1.8% of all STANNOUS FLUORIDE reports
#12 most reported adverse reaction
DYSGEUSIA is the #12 most commonly reported adverse reaction for STANNOUS FLUORIDE, manufactured by Haleon US Holdings LLC. There are 29 FDA adverse event reports linking STANNOUS FLUORIDE to DYSGEUSIA. This represents approximately 1.8% of all 1,587 adverse event reports for this drug.
Patients taking STANNOUS FLUORIDE who experience dysgeusia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSGEUSIA is a less commonly reported adverse event for STANNOUS FLUORIDE, but still significant enough to appear in the safety profile.
In addition to dysgeusia, the following adverse reactions have been reported for STANNOUS FLUORIDE:
The following drugs have also been linked to dysgeusia in FDA adverse event reports:
DYSGEUSIA has been reported as an adverse event in 29 FDA reports for STANNOUS FLUORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSGEUSIA accounts for approximately 1.8% of all adverse event reports for STANNOUS FLUORIDE, making it a notable side effect.
If you experience dysgeusia while taking STANNOUS FLUORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.